Spain· ES:60159
ZELIDERM 200 mg/g CREMA
A medicinal product containing ácido azelaico, registered in Spain by Laboratorios Vinas S.A..
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- ácido azelaico
- Manufacturer
- Laboratorios Vinas S.A.
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 12, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ácido azelaico in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- PolandSkinorenPharmaVitae Sp. z o.o. sp. k.
- CzechiaSKINORENLEO Pharma A/S, Ballerup
- FinlandSkinorenLeo Pharma A/S
- United States10% Azelaic AcidGuangzhou Ariel Medical Technology Co., Ltd.
- NorwayFinaceaLEO PHARMA A/S (Danmark)
- SwedenAzelainsyra Evolan 150 mg/g GelEvolan Pharma AB
- United KingdomFinacea 15% gelLEO Pharma
- FranceFINACEA 15 %, gelLEO PHARMA A/S (DANEMARK)
Authorised across Europe · EMA
The same active substance is authorised in 26 EEA countries. Names it is sold under:
- Austria · Finacea, Skinoren
- Belgium · Skinoren
- Bulgaria · Скинорен, Финацеа
- Cyprus · Skinoren
- Czechia · Skinoren
- Germany · Skinoren
- Denmark · Finacea, Skinoren
- Estonia · Finacea, Skinoren
- Finland · Skinoren
- France · Finacea, Skinoren
- United Kingdom (Northern Ireland) · Finacea, Skinoren
- Greece · Arbonid, Azelderm
- Croatia · Skinoren
- Hungary · Finacea, Skinoren
- Ireland · Skinoren
- Italy · Finacea, Skinoren
- Lithuania · Finacea, Skinoren
- Luxembourg · Skinoren
- Latvia · Finacea, Skinoren
- Norway · Finacea, Skinoren
- Poland · Skinoren, Skinoren Rosacea
- Portugal · Skinoren
- Romania · Skinoren
- Sweden · Azelainsyra Evolan, Finacea
- Slovenia · Skinoren
- Slovakia · Finacea, Skinoren
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/5f08b0c6-95fd-4572-86c2-dba6b708dce8 GET /v1/drugs/5f08b0c6-95fd-4572-86c2-dba6b708dce8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Sin Receta",
"estado": "{\"aut\":762476400000}",
"nregistro": "60159",
"substance": "ácido azelaico"
}See everything about ácido azelaico.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.